Search results
Results from the WOW.Com Content Network
Fortune 500 companies based in Houston [1]: Rank Company name 12: ExxonMobil: 48: Phillips 66: 60: Sysco: 105: Enterprise Products Partners: 106: Hewlett Packard Enterprise: 127: Plains GP Holdings
Pages in category "Pharmaceutical companies of the United States" The following 200 pages are in this category, out of approximately 215 total. This list may not reflect recent changes .
Viatris Pharmaceutical Plant in Istanbul. 27 may 2023. The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. [ 31 ] It owns brands (like Viagra , Xanax , Lipitor ), [ 6 ] [ 32 ] generics , including branded and complex generics, biosimilars , [ 33 ] [ 34 ] and over-the-counter (OTC ...
The Channel Industries Mutual Aid (CIMA) is an American Houston-area non-profit mutual aid network. It is a cooperative among over one hundred emergency response agencies in Harris, Chambers, and Brazoria counties and industrial fire departments from petrochemical refineries along the Houston Ship Channel. CIMA coordinates the distribution of ...
The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. [2] [3] With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas.
Tanox was a biopharmaceutical company based in Houston, Texas.The company was founded by two biomedical research scientists, Nancy T. Chang and Tse Wen Chang in March 1986 with $250,000, which was a large part of their family savings at that time.
Catalent, Inc. (Catalent Pharma Solutions), is an American multinational company, and a subsidiary of Novo Holdings A/S since 2024. It is headquartered in Somerset, New Jersey . It is a provider of drug delivery technologies, drug development , drug manufacturing , biologics , gene therapy , and consumer health products.
In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. The FTC described the merger as having a value of US$1.45 billion, and required the companies to divest several marketed products and development projects as a condition of the approval. [16]